Flashpoint Global Channel Program Welcomes New Talent to Accelerate Growth in EMEA Region
September 19, 2018 06:00 ET
|
Flashpoint
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Flashpoint, the global leader in Business Risk Intelligence (BRI), today announced that industry veteran Roy Pickard has joined the company as channel...
Flashpoint Introduces Threat Response & Readiness Subscription
July 18, 2018 10:02 ET
|
Flashpoint
Flashpoint Professional Service (FPS) helps companies prepare for, as well as, quickly assess and respond to a ransomware or cyber extortion attack NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) --...
RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018
May 30, 2018 08:00 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty...
Flashpoint Accelerates Channel and Strategic Partner Initiatives; Appoints Former IBM Executive Jeff Seifert as Global Channel Chief
April 02, 2018 10:13 ET
|
Flashpoint
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Flashpoint, the global leader in Business Risk Intelligence (BRI), today announced that it has appointed former IBM channel executive Jeff Seifert as...
Qu Biologics invited to present Research Data at International Scientific Meetings
May 03, 2017 12:47 ET
|
Qu Biologics
VANCOUVER, British Columbia, May 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week
May 15, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences
May 01, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...